Nagaileben (TSE:7447) Stock Faces Premium P E Despite Firmer Q4 Profit

The market came into this Nagaileben print almost flat, with the stock drifting only a few percent either way over the past month. Yet the real story sits in profitability. Net income in Q4 landed at ¥603.7 million on revenue of ¥3,937.1 million, while trailing earnings carry a P/E of 18.9x that runs ahead of both peers and the broader medical equipment group. Investors are effectively paying a premium for what now looks like only modest earnings power, which is why today’s price reaction says more about sentiment than about any single quarterly line item.

Like the resilience in Nagaileben’s share price but uneasy about paying a premium P/E for what looks like restrained earnings power right now? Check out the 18 high quality undervalued stocks for ideas that pair firmer profitability with more grounded valuations.

Q4 2026 Earnings Summary

• Revenue (Q4 2026 vs. Q4 2025): ¥3,937.1m vs. ¥3,616.7m (up roughly 8.9%)
• Net Income (Q4 2026 vs. Q4 2025): ¥603.7m vs. ¥506.5m (up about 19.2%)
• Basic EPS (Q4 2026 vs. Q4 2025): ¥20.31 vs. ¥16.62 (higher by approximately 22.2%)
• Trailing 12-month Net Income (TTM, Q4 2026 vs. Q4 2025): ¥2,650m vs. ¥2,573m (slightly higher by around 3.0%)

Prefer clean charts instead of another dense block of earnings tables and footnotes? See how Nagaileben’s valuation compares at a glance with our full visual breakdown in the company report for Nagaileben.

Revenue resilience supports the Nagaileben bull story

For anyone leaning positive on Nagaileben as a steady healthcare supplier, the direction of the latest quarter helps. Q4 revenue sits at ¥3,937.1m against ¥3,616.7m a year earlier, while quarterly net income of ¥603.7m compares with ¥506.5m. Earnings across the last 12 months also edge higher to ¥2,650m from ¥2,573m. That combination of top line and profit growth backs the idea of a durable, essentials driven business rather than a stalled industrial.

Bearish worries now face a tougher earnings test

The more cautious view paints Nagaileben as low growth with squeezed economics. Recent numbers soften that argument. Quarterly revenue and profit are both higher year on year, and basic EPS climbs from ¥16.62 to ¥20.31. Trailing net income also trends up, even if only modestly. None of this removes concerns about procurement pressure or input costs, but it does suggest the immediate risk of earnings slippage looks less acute than a pure bear story might imply.

After a 4.12% dividend that is not well covered by free cash flow, it is fair to ask what else might be lurking under the surface. Review the full Nagaileben risk profile and scan for any structural fault lines already flagged in the risk analysis for Nagaileben which shows 1 important warning sign.

Stay Ahead With Simply Wall St

If the mix of premium P/E and steady Q4 numbers has Nagaileben on your radar, register for free with Simply Wall St and add it to a Watchlist to track share moves against fair value and spot a cleaner entry point. Once you own it or any other holding, keep your decisions grounded with a Portfolio Command Center that filters out background noise and highlights only the updates that matter. For the longer journey, tap into crowd insights and sentiment through the Community so you can see how other investors are interpreting the same figures. That combination helps surface hidden catalysts and risks early, giving you a better chance to react before the wider market moves.

Seeking Alternatives Before Momentum Flies Past

Fresh ideas move fast and the strongest breakouts rarely wait. Scan new setups before the crowd, while the data still matters and entries are not yet crowded. Act now.

• Spot potential cash rich compounds before momentum gets fully caught by the crowd with a curated batch of resilient balance sheet candidates via the list of solid balance sheet and fundamentals stocks (23 results).
• Explore early upside in cash generative AI businesses that are already funding themselves, not burning through equity, by focusing on the 37 profitable AI stocks that aren't just burning cash.
• Identify income focused ideas that aim to keep paying while prices swing, using a refined pool of yield heavy candidates in the 24 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com